Indian Seremar Institute vowed to protect the country from Covid-19 and provided vaccines for the poor worldwide to fight pandemic.

Adar Poonawalla, 40 years old, head of Indian Serum Institute (ISI), the world's largest vaccine manufacturer, has committed to play a leading role in an anti-Covid-19 vaccination effort.

But those promises collapsed.

Poonawalla also acknowledged that the Institute of Serum Institute cannot afford to resolve India's problem and reduce the vaccination burden for poor countries around the world.

"The problem is that no one dares to accept the risks as I did early. I wish others dare to do so," he said.

Adar Poonawalla, Executive Director of India's Serum Institute.

Poonawalla's current difficult situation is what the Indian Serum Institute and Government face.

India's long-term vaccination prospects can be improved after the President Joe Biden government last last week to abandon the Intellectual Property Rights with Vaccine, helping Indian factories can increase production.

ISI has won the support of Prime Minister Modi because it matches the self-reliant Indian story, ready to compairs with large powers in the world that the Prime Minister pursues.

"Our power is extremely poor", Manoj Joshi, a member of the Observe Research Fund (ORF) in New Delhi, said.

Poonawalla took over ISI 10 years ago from Dad, Mr. Cyrus, a billionaire vaccine.

Last year, ISI signed an agreement with Astrazeneca to produce a vaccine dose, called Covishield in India.

In the middle of January and March, ISI pledged to sell about 1.1 billion doses of vaccines in the coming months.

Nepal, the neighboring country of India, previously had to change the purchase and sale law to pay 80% for ISI, equivalent to USI 6.4 million, to buy two million covishield doses.

"I feel sad because we can't continue to help them, but don't forget my first priority is the country, where I gave me everything. I'm still an Indian. I can be one

But ISI also cannot meet the needs of India itself.

ISI's plan is to divide the vaccine at a rate of 50-50 between India and the rest of the world, by directly exporting or through Covax.

ISI cannot fulfill its commitments.

Indian Serum Institute Packing Vaccine in January 1. Photo: Nytimes.

In April, Poonawalla called on President Biden to abandon the sanctions with raw materials for vaccines.

Poonawalla is also criticized for calculating different prices with vaccines for government, states and private hospitals.

Last week, after tripping many criticism, Poonawalla dropped the price to 4 USD / dose.

"People don't understand. They just look at a few simple things and condemn you, without realizing that in the world this item is sold for $ 20 per dose but we only provide it with price 5-

Poonawalla shared he received a lot of complaints, even threatening.

In an interview with Times of London last week, he has received many continuous calls, aggressively asking for instant vaccines from politicians and some "most powerful people India"

But in the interview with Nytimes later, he rejected threats while his office refused to provide detailed information.

People waiting for Vaccine Covid-19 in a hospital in New Delhi last week.

ISI is planning to expand its operations in the UK, with a research and development investment of up to 335 million USD, to finance clinical trials, construction of sales offices and can build factories

"We are under huge pressure from the state government, governments, public, friends and they all want the vaccine. And I'm just trying to distribute it as fairly as possible," Poonawalla